Andrew McCloskey

Donegal Letterkenny
Ash Lane, F91 YW50, Co. Sligo
Ireland

h-index

Research activity per year

Fingerprint

Dive into the research topics where Andrew McCloskey is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

MicroRNA regulation of islet and enteroendocrine peptides: Physiology and therapeutic implications for type 2 diabetes
Carr, E. R., Higgins, P. B., McClenaghan, N. H., Flatt, P. R. & McCloskey, A. G., Jun 2024, In: Peptides. 176, 171196.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Citations (Scopus)
Antidiabetic actions of GPR55 agonist Abn-CBD and sitagliptin in obese-diabetic high fat fed mice
McCloskey, A. G., Miskelly, M. G., Lafferty, R. A., Flatt, P. R. & McKillop, A. M., Feb 2023, In: Biochemical Pharmacology. 208, 115398.
Research output: Contribution to journal › Article › peer-review

Open Access
7 Citations (Scopus)
Development and characterisation of novel, enzymatically stable oxytocin analogues with beneficial antidiabetic effects in high fat fed mice
Mohan, S., McCloskey, A. G., McKillop, A. M., Flatt, P. R., Irwin, N. & Moffett, R. C., Mar 2021, In: Biochimica et Biophysica Acta - General Subjects. 1865, 3, 129811.
Research output: Contribution to journal › Article › peer-review

Open Access
13 Citations (Scopus)
A long-acting, dual-agonist analogue of lamprey GLP-1 shows potent insulinotropic, β-cell protective, and anorexic activities and improves glucose homeostasis in high fat-fed mice
Graham, G. V., McCloskey, A., Abdel-Wahab, Y. H., Conlon, J. M. & Flatt, P. R., 1 Jan 2020, In: Molecular and Cellular Endocrinology. 499, 110584.
Research output: Contribution to journal › Article › peer-review

Open Access
7 Citations (Scopus)
CRISPR/Cas9 gene editing demonstrates metabolic importance of GPR55 in the modulation of GIP release and pancreatic beta cell function
McCloskey, A. G., Miskelly, M. G., Moore, C. B. T., Nesbit, M. A., Christie, K. A., Owolabi, A. I., Flatt, P. R. & McKillop, A. M., Mar 2020, In: Peptides. 125, 170251.
Research output: Contribution to journal › Review article › peer-review

Open Access
20 Citations (Scopus)

Andrew McCloskey

Personal profile

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

MicroRNA regulation of islet and enteroendocrine peptides: Physiology and therapeutic implications for type 2 diabetes

Antidiabetic actions of GPR55 agonist Abn-CBD and sitagliptin in obese-diabetic high fat fed mice

Development and characterisation of novel, enzymatically stable oxytocin analogues with beneficial antidiabetic effects in high fat fed mice

A long-acting, dual-agonist analogue of lamprey GLP-1 shows potent insulinotropic, β-cell protective, and anorexic activities and improves glucose homeostasis in high fat-fed mice

CRISPR/Cas9 gene editing demonstrates metabolic importance of GPR55 in the modulation of GIP release and pancreatic beta cell function

Andrew McCloskey

Personal profile

Fingerprint

Collaborations and top research areas from the last five years

Research output

MicroRNA regulation of islet and enteroendocrine peptides: Physiology and therapeutic implications for type 2 diabetes

Antidiabetic actions of GPR55 agonist Abn-CBD and sitagliptin in obese-diabetic high fat fed mice

Development and characterisation of novel, enzymatically stable oxytocin analogues with beneficial antidiabetic effects in high fat fed mice

A long-acting, dual-agonist analogue of lamprey GLP-1 shows potent insulinotropic, β-cell protective, and anorexic activities and improves glucose homeostasis in high fat-fed mice

CRISPR/Cas9 gene editing demonstrates metabolic importance of GPR55 in the modulation of GIP release and pancreatic beta cell function